JPWO2021095847A1 - - Google Patents
Info
- Publication number
- JPWO2021095847A1 JPWO2021095847A1 JP2021556173A JP2021556173A JPWO2021095847A1 JP WO2021095847 A1 JPWO2021095847 A1 JP WO2021095847A1 JP 2021556173 A JP2021556173 A JP 2021556173A JP 2021556173 A JP2021556173 A JP 2021556173A JP WO2021095847 A1 JPWO2021095847 A1 JP WO2021095847A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/31—Chimeric antigen receptors [CAR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/32—T-cell receptors [TCR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/421—Immunoglobulin superfamily
- A61K40/4211—CD19 or B4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/532—Closed or circular
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019206448 | 2019-11-14 | ||
| PCT/JP2020/042429 WO2021095847A1 (ja) | 2019-11-14 | 2020-11-13 | 抗原特異的受容体遺伝子を環状dnaを用いてt細胞ゲノムに導入する方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021095847A1 true JPWO2021095847A1 (cg-RX-API-DMAC7.html) | 2021-05-20 |
Family
ID=75912989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556173A Pending JPWO2021095847A1 (cg-RX-API-DMAC7.html) | 2019-11-14 | 2020-11-13 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230250415A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4060038A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2021095847A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114901812A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202124718A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021095847A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI921044B (zh) * | 2025-02-12 | 2026-04-01 | 宏碁股份有限公司 | 以胺基酸與來源蛋白關係產生負樣本的方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015068785A1 (ja) * | 2013-11-06 | 2015-05-14 | 国立大学法人広島大学 | 核酸挿入用ベクター |
| WO2019073965A1 (ja) * | 2017-10-10 | 2019-04-18 | 国立大学法人広島大学 | エフェクターT細胞(Teff)抗原受容体を用いた抗原特異的制御性T細胞(Treg)の作出技術 |
| WO2019073964A1 (ja) * | 2017-10-10 | 2019-04-18 | 国立大学法人広島大学 | Platinum TALENを用いたT細胞受容体の完全置換技術 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59942B2 (ja) | 1974-01-11 | 1984-01-09 | 株式会社日立製作所 | ホウデンガタイオンゲンヨウデンゲン |
| US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
| PT2816112T (pt) | 2009-12-10 | 2018-11-20 | Univ Iowa State Res Found Inc | Modificação do adn modificada pelo efector tal |
| GB201407852D0 (en) * | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
| JP6246258B2 (ja) | 2016-04-25 | 2017-12-13 | 国立大学法人広島大学 | Dna結合ドメインを含むポリペプチド |
| WO2018025206A1 (en) * | 2016-08-02 | 2018-02-08 | Kyoto University | Method for genome editing |
| SG11202003798TA (en) * | 2017-10-27 | 2020-05-28 | Univ California | Targeted replacement of endogenous t cell receptors |
| JP7045643B2 (ja) | 2018-05-28 | 2022-04-01 | 日本電気硝子株式会社 | ガラス物品の製造方法及び製造装置 |
-
2020
- 2020-11-13 JP JP2021556173A patent/JPWO2021095847A1/ja active Pending
- 2020-11-13 WO PCT/JP2020/042429 patent/WO2021095847A1/ja not_active Ceased
- 2020-11-13 CN CN202080090344.XA patent/CN114901812A/zh active Pending
- 2020-11-13 EP EP20887397.6A patent/EP4060038A4/en not_active Withdrawn
- 2020-11-13 TW TW109139772A patent/TW202124718A/zh unknown
- 2020-11-13 US US17/776,519 patent/US20230250415A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015068785A1 (ja) * | 2013-11-06 | 2015-05-14 | 国立大学法人広島大学 | 核酸挿入用ベクター |
| WO2019073965A1 (ja) * | 2017-10-10 | 2019-04-18 | 国立大学法人広島大学 | エフェクターT細胞(Teff)抗原受容体を用いた抗原特異的制御性T細胞(Treg)の作出技術 |
| WO2019073964A1 (ja) * | 2017-10-10 | 2019-04-18 | 国立大学法人広島大学 | Platinum TALENを用いたT細胞受容体の完全置換技術 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021095847A1 (ja) | 2021-05-20 |
| EP4060038A4 (en) | 2024-07-10 |
| TW202124718A (zh) | 2021-07-01 |
| US20230250415A1 (en) | 2023-08-10 |
| EP4060038A1 (en) | 2022-09-21 |
| CN114901812A (zh) | 2022-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019017762A2 (cg-RX-API-DMAC7.html) | ||
| BR112021008711A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016141A2 (cg-RX-API-DMAC7.html) | ||
| AU2020104490A5 (cg-RX-API-DMAC7.html) | ||
| BR112019016142A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016138A2 (cg-RX-API-DMAC7.html) | ||
| BR112021012348A2 (cg-RX-API-DMAC7.html) | ||
| AT524962A5 (cg-RX-API-DMAC7.html) | ||
| BR112021013128A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016136A2 (cg-RX-API-DMAC7.html) | ||
| BR102020020846B1 (pt) | Niveladora, e, método para serviço em uma niveladora | |
| BR102020020816B1 (pt) | Veículo, e, método para controlar o movimento de ar através de um veículo com uma ventoinha do veículo | |
| BR102020018650B1 (pt) | Método para preparar óxido de cálcio usando um forno pré- aquecedor de suspensão de múltiplos estágios | |
| BR102020017390B1 (pt) | Bomba multifásica | |
| BR102020016297B1 (pt) | Bolsa de forro para um contentor e método para criar e prender uma bolsa de forro a um contentor | |
| BR102020011722B1 (pt) | Porta de tela para um pacote de radiadores | |
| BR102020005984B1 (pt) | Dispositivo de arranque-gerador combinado, e, conjunto de trem de acionamento | |
| BR102020005860B1 (pt) | Controle de obstrução para um implemento agrícola | |
| BR112021010564B1 (pt) | Sistema de armadilha para animais e método de monitoramento do mesmo | |
| BR112021014592B1 (pt) | Compostos fotosensibilizadores, métodos de fabricação e aplicação em plantas | |
| BR112021013470B1 (pt) | Conector de acesso sem agulha para facilitar a entrega de instrumento a um conjunto de cateter | |
| BR102020000355B1 (pt) | Embreagem que tem dois estágios para aplicar torque variado entre um eixo de entrada e um eixo de saída | |
| BR102019027339B1 (pt) | Sistema de aspersão de água e difusor de sistema de aspersão de água | |
| BR102019026542B1 (pt) | Sistema para detectar e controlar a posição de spoiler de asa de aeronave | |
| BR102019026575B1 (pt) | Atuador, e, aeronave |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20230719 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20230814 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231102 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240806 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20250107 |